Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:8035
TSE:8035Semiconductor

Is It Too Late To Consider Tokyo Electron (TSE:8035) After 1-Year 103.9% Rally?

If you are asking whether Tokyo Electron is still worth considering at today’s price, you are in the right place. This article will focus on what the current share price implies about the company’s value. The stock last closed at ¥44,010, with returns of 0.1% over the past 7 days, 0.5% over 30 days, 19.2% year to date, 103.9% over 1 year and 199.4% over 3 years, so many holders are now wondering what is already priced in. Recent headlines around Tokyo Electron have mainly centred on its role...
NYSE:GLOB
NYSE:GLOBIT

Globant (GLOB) Margin Squeeze To 4.2% Net Challenges Bullish Profitability Narratives

Globant (GLOB) closed out FY 2025 with Q4 revenue of US$612.5 million and basic EPS of US$0.94, alongside net income excluding extra items of US$41.6 million, setting the tone for how the full year’s profitability story lands with investors. Over the last six reported quarters, revenue has moved in a tight band between US$611.1 million and US$642.5 million while quarterly basic EPS has ranged from a loss of US$0.05 to a high of US$1.00, reflecting shifting earnings power that puts the focus...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics Resets Commercial Model To Pursue Higher Quality Growth

PROCEPT BioRobotics (NasdaqGM:PRCT) has overhauled its commercial model, implementing a major realignment of its sales organization and pricing strategy. The company has removed bulk purchase discounts and created a dedicated team focused on driving greater procedural adoption. These changes come alongside significant procedure growth and a reset in financial guidance, marking a key shift in how the company pursues profitability and market expansion. PROCEPT BioRobotics focuses on robotic...
NasdaqGS:SND
NasdaqGS:SNDEnergy Services

Smart Sand (SND) Q4 Results Highlight Thin 0.4% Margin Challenge To Bullish Narratives

Smart Sand (SND) has wrapped up FY 2025 with fourth quarter revenue of US$86.0 million, basic EPS of US$0.03 and net income of US$1.2 million, setting the stage for investors to reassess how the business is converting its top line into profits. Over the past few quarters, the company has seen revenue move between US$65.6 million and US$92.8 million per quarter, while basic EPS has ranged from a loss of US$0.62 to a profit of US$0.55, giving a wide view of how earnings have tracked against...
NYSE:VIA
NYSE:VIASoftware

Via Transportation (VIA) Q4 Loss Narrowing Tests Bearish Profitability Narrative

Via Transportation (VIA) FY 2025 earnings recap Via Transportation (VIA) just closed out FY 2025 with Q4 revenue of US$118.9 million and a basic EPS loss of US$0.28, while trailing twelve month revenue reached US$434.3 million against a full year EPS loss of US$1.21. The company has seen quarterly revenue move from US$83.3 million in Q3 2024 to US$118.9 million in Q4 2025, as basic EPS ranged between a loss of US$1.70 and US$0.28 over the same stretch, and over the last year management...
NYSE:SWX
NYSE:SWXGas Utilities

Is Southwest Gas Holdings (SWX) Pricing Reflecting Recent Utility Sector Policy Focus?

If you are wondering whether Southwest Gas Holdings at around US$88 per share offers good value today, you are not alone; many investors are trying to work out what a fair price looks like. The stock has returned 0.7% over the last week, 7.6% over the past month, 10.0% year to date, 21.3% over one year, 62.5% over three years and 51.5% over five years, which naturally raises questions about how its current price lines up with its fundamentals. Recent news flow around regulated utilities, gas...
NYSE:UNFI
NYSE:UNFIConsumer Retailing

United Natural Foods Showcases Private Labels And Health Trends For Growth

United Natural Foods (NYSE:UNFI) hosted its 2026 Spring and Summer Selling Show, bringing together thousands of retailers and suppliers. The company unveiled nearly 50 new private label products across categories at the event. Key themes included healthier food offerings, private brand development, and growing interest in gut health. For you as an investor, this matters because UNFI sits at the center of the natural, specialty, and conventional grocery supply chain, connecting brands with...
NYSE:XYL
NYSE:XYLMachinery

Xylem Approves US$1.5b Buyback As Shares Trade Below Estimates

Xylem (NYSE:XYL) has authorized a new share repurchase program of up to $1.5b. The program allows the company to buy back shares opportunistically over time. The announcement comes with Xylem shares recently trading around $129.56. Xylem, trading on the NYSE under the ticker XYL, is moving ahead with a sizeable $1.5b buyback plan at a share price of about $129.56. Over the past 3 years, the stock has returned 29.3%, and 37.1% over 5 years, which gives context for how management is choosing...
NasdaqGM:XENE
NasdaqGM:XENEBiotechs

Xenon Pharmaceuticals XENE Loss Widening Tests Bullish Pipeline Narrative

Xenon Pharmaceuticals (XENE) has put fresh numbers on the table for FY 2025, with first half revenue at US$7.5 million and a basic EPS loss of US$1.90, alongside a trailing twelve month EPS loss of US$4.36. The company has seen revenue move from US$0 in both halves of 2024 to US$7.5 million in the latest half. Basic EPS losses widened from US$1.36 and US$1.64 in the first and second halves of 2024 to US$1.90 most recently and a trailing twelve month net loss of US$345.91 million, keeping...
NYSE:AHR
NYSE:AHRHealth Care REITs

American Healthcare REIT (AHR) FFO Profile Becomes Central Test Of Bullish Growth Narratives

American Healthcare REIT (AHR) has wrapped up FY 2025 with Q4 revenue of US$604.1 million and basic EPS of US$0.06, rounding out a trailing twelve month picture that shows total revenue of about US$2.3 billion and basic EPS of US$0.42. Over the past few quarters the REIT has seen revenue move from US$540.2 million in Q4 2024 to US$604.1 million in Q4 2025, while quarterly EPS shifted from a loss of US$0.20 per share to a profit of US$0.06 per share. This sets up a year where investors will be...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

Assessing GoodRx Holdings (GDRX) Valuation After Employer Direct Launch And Post Earnings Analyst Shifts

GoodRx Holdings (GDRX) is back in focus after launching its Employer Direct platform to help companies reduce high-impact brand drug costs, alongside 2025 earnings, fresh 2026 guidance, and a cluster of analyst rating changes. See our latest analysis for GoodRx Holdings. GoodRx’s recent earnings update, 2026 revenue guidance and the Employer Direct launch have been followed by a sharp reset in sentiment, with a 7 day share price return of 24.29% decline and a 1 year total shareholder return...
NYSE:BUR
NYSE:BURDiversified Financial

Burford Capital (NYSE:BUR) Q4 Loss And Margin Compression Test Bullish Growth Narrative

Burford Capital (NYSE:BUR) rounded out FY 2025 with Q4 revenue of US$33.4 million and a basic EPS loss of US$0.17, as quarterly earnings swung back into the red despite a profitable first half. The company has seen quarterly revenue move from US$244.9 million and EPS of US$0.62 in Q3 2024 to US$178.0 million and EPS of US$0.40 in Q2 2025, and then to US$64.7 million with an EPS loss of US$0.09 in Q3 2025 before landing at the latest Q4 figures. This sets up a results season in which investors...
NYSE:THR
NYSE:THRElectrical

Is It Too Late To Consider Thermon Group Holdings (THR) After Its Strong Share Price Run?

If you are wondering whether Thermon Group Holdings is still attractively priced or already reflecting most of its potential, you are in the right place for a valuation-focused look at the stock. The share price, last closing at US$50.78, comes with a mixed return profile, with a 0.5% decline over 7 days, a 16.9% gain over 30 days, 34.9% year to date, 72.1% over 1 year, 84.6% over 3 years and 136.7% over 5 years. Recent price action sits alongside ongoing news flow around Thermon Group...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

Hepsiburada (HEPS) Q4 Loss Worsening Tests Bullish Margin Improvement Narrative

D-Market Elektronik Hizmetler ve Ticaret (NasdaqGS:HEPS) has wrapped up FY 2025 with Q4 revenue of approximately ₺30.3b and a net loss of about ₺3.2b, capping a year in which trailing twelve month revenue reached roughly ₺84.7b alongside a total net loss of around ₺5.7b. The company reported quarterly revenue increasing from about ₺20.4b in Q4 2024 to ₺30.3b in Q4 2025, while quarterly net losses widened from roughly ₺724m to about ₺3.2b over the same period. EPS on a trailing twelve month...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

MannKind (MNKD) Margin Compression To 1.7% TTM Net Margin Fuels Bearish Narratives

MannKind (MNKD) has wrapped up FY 2025 with fourth quarter revenue of US$112 million and a basic EPS loss of US$0.05, setting a clear focal point for investors watching how its income statement is evolving. Over recent periods the company has seen revenue move from US$70 million in Q3 2024 to US$82 million in Q3 2025, while quarterly EPS has ranged from US$0.04 in Q1 2025 to a small profit of US$0.03 in Q3 2025 before this latest loss. This puts the spotlight firmly on how durable its margins...
TSX:CRON
TSX:CRONPharmaceuticals

Cronos Group (TSX:CRON) Revenue Jump To US$44.5 Million Tests Profitability Narrative

Cronos Group (TSX:CRON) closed FY 2025 with Q4 revenue of US$44.5 million and a basic EPS loss of US$0.00, alongside trailing twelve month revenue of US$146.6 million and a basic EPS loss of US$0.02. The company has seen quarterly revenue move from US$30.3 million in Q4 2024 to US$44.5 million in Q4 2025, while basic EPS has shifted between a profit of US$0.11 in Q4 2024 and a small loss in the latest quarter. This sets up a story in which investors will be watching how quickly margins can...
NYSE:ALEX
NYSE:ALEXREITs

Alexander & Baldwin (ALEX) Q4 FFO Loss Challenges Bullish Hawaii REIT Narratives

Alexander & Baldwin (ALEX) has wrapped up FY 2025 with fourth quarter revenue of US$43.8 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$206.7 million and EPS of US$0.89. Over the last six quarters, the company has seen quarterly revenue move from US$63.2 million in Q4 2024 to US$56.8 million in Q1 2025 and down to US$43.8 million in Q4 2025, while quarterly EPS moved from US$0.18 to US$0.29 and then US$0.05. This sets up a mixed backdrop for a stock trading at...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

C4 Therapeutics (CCCC) Quarterly Loss Narrows To US$20.5m Challenging Persistent Bearish Narratives

C4 Therapeutics (CCCC) just posted its FY 2025 Q4 numbers, with revenue of US$11.0 million and a quarterly loss translating to basic EPS of US$0.18, set against a trailing twelve month loss of US$105.0 million and EPS of US$1.27 on revenue of US$35.9 million. Over recent quarters, the company has seen revenue move between US$5.2 million and US$15.4 million, while quarterly EPS has ranged from US$0.35 to US$0.49 and quarterly losses from US$24.7 million to US$34.6 million. The key question for...
NasdaqGM:GDEN
NasdaqGM:GDENHospitality

Golden Entertainment (GDEN) Loss Deepens In Q4 EPS Miss Challenges Profit-Recovery Narrative

Golden Entertainment (GDEN) has wrapped up FY 2025 with Q4 revenue of US$155.6 million and a basic EPS loss of US$0.33, alongside net income excluding extra items of a US$8.5 million loss. Over recent periods, the company has seen quarterly revenue move between US$154.8 million and US$164.2 million, while EPS has swung from a profit of US$0.18 in Q3 2024 to a loss of US$0.33 in Q4 2025. This leaves investors watching how quickly margins can stabilize from here. See our full analysis for...
NYSE:MPT
NYSE:MPTHealth Care REITs

FFO Recovery At Medical Properties Trust (MPW) Challenges Bearish Cash Flow Narratives

Latest Earnings Snapshot Medical Properties Trust (MPW) has wrapped up FY 2025 with fourth quarter revenue of US$294.5 million, basic EPS of US$0.03, and Funds From Operations of US$115.9 million, giving investors a cleaner read on cash based performance for a healthcare REIT. The company has seen revenue move from US$247.5 million in Q3 2024 to US$234.8 million in Q4 2024 and then to US$294.5 million in Q4 2025. Basic EPS shifted from a loss of US$0.69 in Q4 2024 to a loss of US$0.20 in Q1...
NYSE:KNSL
NYSE:KNSLInsurance

Insider Sale And Cooling Growth Reframe Kinsale Capital Group Outlook

A Kinsale Capital Group (NYSE:KNSL) board director recently sold shares, drawing fresh attention to insider activity at the company. Management has flagged moderating premium growth and increasing competition in its core markets. Together, these updates point to a changing operating backdrop that investors are now reassessing. Kinsale Capital Group, trading at $389.67 as of the last close, comes into this news with a mixed recent record. The stock is up 4.4% over the past week, flat over...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp (NTAP) Margin Improvement Reinforces Bullish Profitability Narrative In Q3 2026

NetApp (NTAP) has put another solid quarter on the board, with Q3 2026 revenue of US$1.7 billion, basic EPS of US$1.69 and trailing twelve month EPS of US$6.08 helping frame how the latest print fits into its recent performance. The company has seen revenue move from US$1.66 billion in Q2 2025 to US$1.71 billion in Q3 2026, while quarterly basic EPS has ranged between US$1.16 and US$1.69 over that period. This sets up a story where a stable top line and consistent earnings keep margins firmly...
NYSE:NP
NYSE:NPInsurance

Neptune Insurance Holdings (NP) Trailing Loss Challenges Bullish High Margin Narratives

Neptune Insurance Holdings (NP) closed FY 2025 with Q4 revenue of US$43.8 million and basic EPS of US$0.03, set against trailing 12 month revenue of US$159.6 million and a basic EPS loss of US$0.26. The company has seen quarterly revenue move from US$31.5 million in Q4 2024 to US$43.8 million in Q4 2025. Basic EPS has ranged from a loss of US$0.21 in Q1 2025 to US$0.06 in the year earlier quarter, leaving investors weighing solid top line progress against margins that are still under...
NYSE:DSX
NYSE:DSXShipping

Diana Shipping (NYSE:DSX) One Off US$17.3m Gain Challenges Earnings Quality Narrative

Diana Shipping (NYSE:DSX) has just wrapped up FY 2025 with fourth quarter revenue of US$52.1 million and basic EPS of US$0.02, rounding out a year where trailing twelve month revenue came in at US$213.5 million and EPS at US$0.11. Over recent periods, the company has seen quarterly revenue move between US$51.9 million and US$54.9 million, while basic EPS ranged from about US$0.01 to US$0.07. During the same timeframe, trailing twelve month EPS rose from US$0.06 to US$0.11 as revenue shifted...